Malignant Hypertension

Authors

  • J. Demiselle Département de réanimation médicale et de médecine hyperbare, centre hospitalier universitaire
  • F. Beloncle Département de réanimation médicale et de médecine hyperbare, centre hospitalier universitaire
  • P. Asfar Département de réanimation médicale et de médecine hyperbare, centre hospitalier universitaire
  • N. Lerolle Département de réanimation médicale et de médecine hyperbare, centre hospitalier universitaire

DOI:

https://doi.org/10.1007/s13546-015-1051-9

Keywords:

Neuromuscular junction, Myasthenic crisis, Vital capacity

Abstract

Malignant hypertension is defined by a rise in blood pressure associated with stage III or IV retinopathy. This situation remains rare but may have a fatal issue if not recognized and treated appropriately. The understanding of the pathogenesis of malignant hypertension with the importance of renin angiotensin aldosteron system activation allowed for an improvement in early and long term outcomes. The key point is to determine whether the rise in blood pressure is associated with organ failure or not, to differentiate hypertensive urgencies from emergencies. In hypertensive emergencies, the rapid introduction of antihypertensive drugs is recommended. The aim of this review is to propose guidance for malignant hypertension diagnosis, cause assessment, and treatment.

Published

2015-03-10

How to Cite

Demiselle, J., Beloncle, F., Asfar, P., & Lerolle, N. (2015). Malignant Hypertension. Médecine Intensive Réanimation, 24(2), 165–171. https://doi.org/10.1007/s13546-015-1051-9

Most read articles by the same author(s)

<< < 1 2 3